Class information for: |
Basic class information |
| Class id | #P | Avg. number of references |
Database coverage of references |
|---|---|---|---|
| 23997 | 327 | 35.8 | 83% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 8 | 4 | CARDIAC & CARDIOVASCULAR SYSTEM//PERIPHERAL VASCULAR DISEASES//CARDIOL | 1276458 |
| 62 | 3 | CARDIAC & CARDIOVASCULAR SYSTEM//HEART FAILURE//PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 86105 |
| 942 | 2 | HEART FAILURE//ACUTE HEART FAILURE//EUROPEAN JOURNAL OF HEART FAILURE | 10944 |
| 23997 | 1 | HEART FAILURE COMPLICATIONS MORTALITY//KENTHLTH//AALBORG THROMBOSIS IHRIT | 327 |
Terms with highest relevance score |
| rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|---|
| 1 | HEART FAILURE COMPLICATIONS MORTALITY | authKW | 280139 | 1% | 100% | 3 |
| 2 | KENTHLTH | address | 210103 | 1% | 75% | 3 |
| 3 | AALBORG THROMBOSIS IHRIT | address | 93380 | 0% | 100% | 1 |
| 4 | AMERICAN COLLEGE OF CARDIOLOGY AMERICAN HEART ASSOCIATION GUIDELINES FOR THE EVALUATION AND MANAGEMENT OF CHR | authKW | 93380 | 0% | 100% | 1 |
| 5 | ANGIOTENSIN 2 RECEPTOR BLOCKER | authKW | 93380 | 0% | 100% | 1 |
| 6 | ANGIOTENSIN CONVENING ENZYME INHIBITION | authKW | 93380 | 0% | 100% | 1 |
| 7 | ANGIOTENSIN CONVERTING ENZYME INHIBITORS INTERACTION | authKW | 93380 | 0% | 100% | 1 |
| 8 | ANTICOGULANT | authKW | 93380 | 0% | 100% | 1 |
| 9 | ANTITHROMBOSIS THERAPY | authKW | 93380 | 0% | 100% | 1 |
| 10 | CARDIOEMBOLIC ISCHEMIC STROKE | authKW | 93380 | 0% | 100% | 1 |
Web of Science journal categories |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | Cardiac & Cardiovascular System | 6582 | 55% | 0% | 181 |
| 2 | Peripheral Vascular Diseases | 1632 | 21% | 0% | 69 |
| 3 | Hematology | 234 | 9% | 0% | 29 |
| 4 | Medicine, General & Internal | 201 | 13% | 0% | 42 |
| 5 | Clinical Neurology | 26 | 6% | 0% | 18 |
| 6 | Pharmacology & Pharmacy | 23 | 8% | 0% | 25 |
| 7 | Geriatrics & Gerontology | 18 | 2% | 0% | 5 |
| 8 | Gerontology | 11 | 1% | 0% | 3 |
| 9 | Respiratory System | 7 | 2% | 0% | 6 |
| 10 | Critical Care Medicine | 3 | 1% | 0% | 3 |
Address terms |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | KENTHLTH | 210103 | 1% | 75% | 3 |
| 2 | AALBORG THROMBOSIS IHRIT | 93380 | 0% | 100% | 1 |
| 3 | CARDIOVASCR SCI | 93380 | 0% | 100% | 1 |
| 4 | CLIN EVALUAT SCIIHPME | 93380 | 0% | 100% | 1 |
| 5 | CLIN OUTCOMES PERFORMANCE | 93380 | 0% | 100% | 1 |
| 6 | DE GASPERIS CARDIAC | 93380 | 0% | 100% | 1 |
| 7 | FARMACOL TER IA | 93380 | 0% | 100% | 1 |
| 8 | FUNCT EXPT SCI | 93380 | 0% | 100% | 1 |
| 9 | GLOBAL HLTH ECON OUTCOMES GEN MED | 93380 | 0% | 100% | 1 |
| 10 | HEART VASC H350 | 93380 | 0% | 100% | 1 |
Journals |
| Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
|---|---|---|---|---|---|
| 1 | EUROPEAN JOURNAL OF HEART FAILURE | 28877 | 8% | 1% | 27 |
| 2 | JOURNAL OF CARDIAC FAILURE | 5447 | 3% | 1% | 10 |
| 3 | CIRCULATION-HEART FAILURE | 2698 | 2% | 1% | 5 |
| 4 | JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2138 | 6% | 0% | 19 |
| 5 | AMERICAN HEART JOURNAL | 1451 | 5% | 0% | 15 |
| 6 | JOURNAL OF THROMBOSIS AND THROMBOLYSIS | 1253 | 2% | 0% | 5 |
| 7 | CARDIOLOGY IN REVIEW | 1003 | 1% | 1% | 2 |
| 8 | JOURNAL OF STROKE & CEREBROVASCULAR DISEASES | 993 | 2% | 0% | 5 |
| 9 | EUROPEAN HEART JOURNAL SUPPLEMENTS | 813 | 1% | 0% | 3 |
| 10 | ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY | 731 | 1% | 0% | 2 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
| Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
|---|---|---|---|---|
| 1 | SUBRAMANIAM, V , DAVIS, RC , SHANTSILA, E , LIP, GYH , (2009) ANTITHROMBOTIC THERAPY FOR HEART FAILURE IN SINUS RHYTHM.FUNDAMENTAL & CLINICAL PHARMACOLOGY. VOL. 23. ISSUE 6. P. 705 -717 | 44 | 44% | 5 |
| 2 | MILICIC, D , SAMARDZIC, J , PETRICEVIC, M , (2014) ANTITHROMBOTICS IN HEART FAILURE.CROATIAN MEDICAL JOURNAL. VOL. 55. ISSUE 6. P. 621 -627 | 26 | 62% | 0 |
| 3 | CARAZO, M , BERGER, JS , REYENTOVICH, A , KATZ, SD , (2016) ROLE OF ANTIPLATELET THERAPY AND ANTICOAGULATION IN NONISCHEMIC CARDIOMYOPATHY.CARDIOLOGY IN REVIEW. VOL. 24. ISSUE 5. P. 211 -217 | 28 | 52% | 0 |
| 4 | JUHLIN, T , JONSSON, BAG , HOGLUND, P , (2008) RENAL EFFECTS OF ASPIRIN ARE CLEARLY DOSE-DEPENDENT AND ARE OF CLINICAL IMPORTANCE FROM A DOSE OF 160 MG.EUROPEAN JOURNAL OF HEART FAILURE. VOL. 10. ISSUE 9. P. 892-898 | 23 | 72% | 11 |
| 5 | AUMEGEAT, V , LAMBLIN, N , DE GROOTE, P , MCFADDEN, EP , MILLAIRE, A , BAUTERS, C , LABLANCHE, JM , (2003) ASPIRIN DOES NOT ADVERSELY AFFECT SURVIVAL IN PATIENTS WITH STABLE CONGESTIVE HEART FAILURE TREATED WITH ANGIOTENSIN-CONVERTING ENZYME INHIBITORS.CHEST. VOL. 124. ISSUE 4. P. 1250-1258 | 20 | 87% | 8 |
| 6 | MASSIE, BM , KROL, WF , AMMON, SE , ARMSTRONG, PW , CLELAND, JG , COLLINS, JF , EZEKOWITZ, M , JAFRI, SM , O'CONNOR, CM , PACKER, M , ET AL (2004) THE WARFARIN AND ANTIPLATELET THERAPY IN HEART FAILURE TRIAL (WATCH): RATIONALE, DESIGN, AND BASELINE PATIENT CHARACTERISTICS.JOURNAL OF CARDIAC FAILURE. VOL. 10. ISSUE 2. P. 101-112 | 23 | 68% | 50 |
| 7 | MENTZ, RJ , LAZZARINI, V , FIUZAT, M , METRA, M , O'CONNOR, CM , FELKER, GM , (2013) IS THERE A RATIONALE FOR ANTIPLATELET THERAPY IN ACUTE HEART FAILURE.CIRCULATION-HEART FAILURE. VOL. 6. ISSUE 4. P. 869-876 | 27 | 48% | 1 |
| 8 | ALTIN, T , KILICKAP, M , (2007) USE OF ASPIRIN IN PATIENTS TAKING ANGIOTENSIN CONVERTING ENZYME INHIBITORS.ANADOLU KARDIYOLOJI DERGISI-THE ANATOLIAN JOURNAL OF CARDIOLOGY. VOL. 7. ISSUE . P. 14-19 | 24 | 62% | 0 |
| 9 | HAEUSLER, KG , LAUFS, U , ENDRES, M , (2011) CHRONIC HEART FAILURE AND ISCHEMIC STROKE.STROKE. VOL. 42. ISSUE 10. P. 2977 -U483 | 24 | 50% | 23 |
| 10 | BETTARI, L , FIUZAT, M , BECKER, R , FELKER, GM , METRA, M , O'CONNOR, CM , (2011) THROMBOEMBOLISM AND ANTITHROMBOTIC THERAPY IN PATIENTS WITH HEART FAILURE IN SINUS RHYTHM CURRENT STATUS AND FUTURE DIRECTIONS.CIRCULATION-HEART FAILURE. VOL. 4. ISSUE 3. P. 361-368 | 22 | 56% | 12 |
Classes with closest relation at Level 1 |